Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
COMMENT
Kanade Shinkai
No abstract text is available yet for this article.
March 22, 2023: JAMA Dermatology
#2
JOURNAL ARTICLE
Gabriella Santa Lucia, Alan Snyder, Almeera Lateef, Alex Drohan, Mathew J Gregoski, Virginia Barton, Dirk M Elston
IMPORTANCE: Disseminated superficial actinic porokeratosis (DSAP) is an inherited or sporadic disorder of keratinization associated with germline variations. There is no effective standard of care therapy for DSAP, but treatment with topical lovastatin combined with cholesterol cream has shown promise. OBJECTIVES: To evaluate and compare the safety and efficacy of topical lovastatin 2% plus cholesterol 2% cream (lovastatin-cholesterol) and topical lovastatin 2% cream (lovastatin) alone in adults diagnosed with DSAP...
March 22, 2023: JAMA Dermatology
#3
JOURNAL ARTICLE
François-Xavier Blanchet, Mayda Rahi, Marie Merlant, Mathilde Gare, Florence Brunet-Possenti, Vincent Descamps, Fabrice Bouscarat
No abstract text is available yet for this article.
March 22, 2023: JAMA Dermatology
#4
JOURNAL ARTICLE
Sarah A Ibrahim, Luke S Wallis, David C Reid
No abstract text is available yet for this article.
March 22, 2023: JAMA Dermatology
#5
JOURNAL ARTICLE
Paige W Wolstencroft, Natasha C Zacher, Katie Scotellaro, Sierra Centkowski, Bernice Y Kwong
IMPORTANCE: The US health care system generates substantial global waste. Skin biopsies are frequently performed by dermatologists and represent a practical and scalable opportunity for waste reduction interventions in dermatology clinics. OBJECTIVE: To develop and implement a systematic framework for decreasing skin biopsy tray waste in dermatology clinics. DESIGN, SETTING, AND PARTICIPANTS: This quality improvement study was conducted at 4 outpatient clinic sites within a single institution between October 2021 and April 2022...
March 17, 2023: JAMA Dermatology
#6
JOURNAL ARTICLE
Aaron Gabriel W Sandoval, Lauren T Vaughn, Jennifer T Huang, John S Barbieri
IMPORTANCE: Tumor necrosis factor-α inhibitors (TNFis) approved to treat several inflammatory diseases are sometimes used off label to treat severe forms of acne that are refractory to conventional therapies. However, use of TNFis can also be followed by acne occurrence, suggesting an association between TNFis and acne. Most of the literature on the topic comprises case reports and series that have not been reviewed in a systematic manner. OBJECTIVE: To characterize the demographic characteristics, clinical presentations, treatments, and outcomes of patients receiving TNFis to treat acne and patients who develop acne following treatment of other conditions with TNFis...
March 17, 2023: JAMA Dermatology
#7
JOURNAL ARTICLE
Katharina Shaw, Stephanie Sanchez-Melendez, Dustin Taylor, Julia Barker, Avery LaChance, Neda Shahriari, Ruth Ann Vleugels
No abstract text is available yet for this article.
March 15, 2023: JAMA Dermatology
#8
JOURNAL ARTICLE
Kailas Vodrahalli, Justin Ko, Albert S Chiou, Roberto Novoa, Abubakar Abid, Michelle Phung, Kiana Yekrang, Paige Petrone, James Zou, Roxana Daneshjou
IMPORTANCE: Telemedicine use accelerated during the COVID-19 pandemic, and skin conditions were a common use case. However, many images submitted may be of insufficient quality for making a clinical determination. OBJECTIVE: To determine whether an artificial intelligence (AI) decision support tool, a machine learning algorithm, could improve the quality of images submitted for telemedicine by providing real-time feedback and explanations to patients. DESIGN, SETTING, AND PARTICIPANTS: This quality improvement study with an AI performance component and single-arm clinical pilot study component was conducted from March 2020 to October 2021...
March 15, 2023: JAMA Dermatology
#9
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
March 15, 2023: JAMA Dermatology
#10
JOURNAL ARTICLE
Noreen Mohsin, Mackenzie R Martin, Danielle J Reed, Serena M Vilasi, Lingling Miao, Natasha T Hill, Isaac Brownell
IMPORTANCE: Racial and ethnic differences in skin cancer outcomes are understudied. Delineating these differences in Merkel cell carcinoma (MCC) is needed to better understand this rare disease. OBJECTIVE: To determine how MCC presentation and outcomes differ across racial and ethnic groups. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included patients diagnosed with MCC and followed up from 2000 through 2018 in the 18 population-based cancer registries of the National Cancer Institute's Surveillance, Epidemiology, and End Results Program...
March 15, 2023: JAMA Dermatology
#11
JOURNAL ARTICLE
Alan C Geller, Martin A Weinstock
No abstract text is available yet for this article.
March 15, 2023: JAMA Dermatology
#12
JOURNAL ARTICLE
Woo Chiao Tay, Joyce Siong-See Lee, Etienne Cho Ee Wang
No abstract text is available yet for this article.
March 15, 2023: JAMA Dermatology
#13
JOURNAL ARTICLE
Mohammed Kashani-Sabet, Sancy A Leachman, Jennifer A Stein, Jack L Arbiser, Elizabeth G Berry, Julide T Celebi, Clara Curiel-Lewandrowski, Laura K Ferris, Jane M Grant-Kels, Douglas Grossman, Rajan P Kulkarni, Michael A Marchetti, Kelly C Nelson, David Polsky, Elizabeth V Seiverling, Susan M Swetter, Hensin Tsao, Alexandra Verdieck-Devlaeminck, Maria L Wei, Anna Bar, Edmund K Bartlett, Jean L Bolognia, Tawnya L Bowles, Kelly B Cha, Emily Y Chu, Rebecca I Hartman, Elena B Hawryluk, Risa M Jampel, Lilit Karapetyan, Meenal Kheterpal, David H Lawson, Philip D Leming, Tracey N Liebman, Michael E Ming, Debjani Sahni, Stephanie A Savory, Saba S Shaikh, Arthur J Sober, Vernon K Sondak, Natalie Spaccarelli, Richard P Usatine, Suraj Venna, John M Kirkwood
IMPORTANCE: Therapy for advanced melanoma has transformed during the past decade, but early detection and prognostic assessment of cutaneous melanoma (CM) remain paramount goals. Best practices for screening and use of pigmented lesion evaluation tools and gene expression profile (GEP) testing in CM remain to be defined. OBJECTIVE: To provide consensus recommendations on optimal screening practices and prebiopsy diagnostic, postbiopsy diagnostic, and prognostic assessment of CM...
March 15, 2023: JAMA Dermatology
#14
JOURNAL ARTICLE
Kevin Yang, Charles B Lau, William C Lau, Vinod E Nambudiri, Alice J Watson
No abstract text is available yet for this article.
March 8, 2023: JAMA Dermatology
#15
JOURNAL ARTICLE
Pascal Joly, Audrey Lafon, Estelle Houivet, Nathalie Donnadieu, Marie-Aleth Richard, Alain Dupuy, Emmanuel Delaporte, Philippe Bernard, Laurent Machet, Antonella Tosti, Veronique Del Marmol, Ramon Grimalt, Pierre A de Viragh, Jacques Benichou, Olivier Chosidow, Philippe Assouly, Pascal Reygagne
IMPORTANCE: Poor therapeutic results have been reported in patients with alopecia areata totalis (AT) or universalis (AU), the most severe and disabling types of alopecia areata (AA). Methotrexate, an inexpensive treatment, might be effective in AU and AT. OBJECTIVE: To evaluate the efficacy and tolerance of methotrexate alone or combined with low-dose prednisone in patients with chronic and recalcitrant AT and AU. DESIGN, SETTING, AND PARTICIPANTS: This academic, multicenter, double-blind, randomized clinical trial was conducted at 8 dermatology departments at university hospitals between March 2014 and December 2016 and included adult patients with AT or AU evolving for more than 6 months despite previous topical and systemic treatments...
March 8, 2023: JAMA Dermatology
#16
JOURNAL ARTICLE
Suzanne Xu, Robert J Patrignelli, Sarika Ramachandran, Fotios Koumpouras, Deborah Desir, Christine J Ko, Jeff R Gehlhausen
No abstract text is available yet for this article.
March 8, 2023: JAMA Dermatology
#17
JOURNAL ARTICLE
Yuki Miyamoto, Hiroyuki Ohbe, Ryosuke Kumazawa, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga, Bon Ohta
IMPORTANCE: Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are severe cutaneous adverse reactions, and patients with SJS/TEN frequently require intensive care. However, there is limited evidence on the clinical outcomes of immunomodulating therapy, including plasmapheresis and intravenous immunoglobulin (IVIG) in patients with SJS/TEN. OBJECTIVE: To compare clinical outcomes of patients with SJS/TEN who were treated with plasmapheresis first vs IVIG first after ineffective systemic corticosteroid therapy...
March 8, 2023: JAMA Dermatology
#18
JOURNAL ARTICLE
Sarah E Fillingim, Christina Artz, Pranita Rambhatla
No abstract text is available yet for this article.
March 8, 2023: JAMA Dermatology
#19
JOURNAL ARTICLE
Emily Baumrin, Laura X Baker, Michael Byrne, Paul J Martin, Mary E Flowers, Lynn Onstad, Najla El Jurdi, Heidi Chen, Alicia Beeghly-Fadiel, Stephanie J Lee, Eric R Tkaczyk
IMPORTANCE: Prior studies have demonstrated an association between cutaneous chronic graft-vs-host disease (cGVHD) and mortality. Assessment of the prognostic value of different measures of disease severity would assist in risk stratification. OBJECTIVE: To compare the prognostic value of body surface area (BSA) and National Institutes of Health (NIH) Skin Score on survival outcomes stratified by erythema and sclerosis subtypes of cGVHD. DESIGN, SETTING, AND PARTICIPANTS: Multicenter prospective cohort study from the Chronic Graft-vs-Host Disease Consortium including 9 medical centers in the US, enrolled from 2007 through 2012 and followed until 2018...
March 8, 2023: JAMA Dermatology
#20
JOURNAL ARTICLE
Yue-Hua Li, Cheng-Jiang Wei, Zhi-Chao Wang
No abstract text is available yet for this article.
March 1, 2023: JAMA Dermatology
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
